Progress interrogating TRPMPZQ as the target of praziquantel
PLOS Neglected Tropical Diseases · 2024
DOI: 10.1371/journal.pntd.0011929 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Jonathan S Marchant. Beteiligte Einrichtung: Department of Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America. Hauptthemen laut MEDLINE: Anthelmintics, Transient Receptor Potential Channels. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Marcus Family.
Abstract (Originalsprache)
The drug praziquantel (PZQ) has served as the long-standing drug therapy for treatment of infections caused by parasitic flatworms. These encompass diseases caused by parasitic blood, lung, and liver flukes, as well as various tapeworm infections. Despite a history of clinical usage spanning over 4 decades, the parasite target of PZQ has long resisted identification. However, a flatworm transient receptor potential ion channel from the melastatin subfamily (TRPM PZQ ) was recently identified as a target for PZQ action. Here, recent experimental progress interrogating TRPM PZQ is evaluated, encompassing biochemical, pharmacological, genetic, and comparative phylogenetic data that highlight the properties of this ion channel. Various lines of evidence that support TRPM PZQ being the therapeutic target of PZQ are presented, together with additional priorities for further research into the mechanism of action of this important clinical drug.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
ORCID-Profile: Jonathan S Marchant
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Marcus Family
Zitieren
APA
Marchant, J. S. (2024). Progress interrogating TRPMPZQ as the target of praziquantel. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011929
Vancouver
Marchant JS. Progress interrogating TRPMPZQ as the target of praziquantel. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0011929
BibTeX
@article{Marchant2024,
author = {Marchant, Jonathan S},
title = {Progress interrogating TRPMPZQ as the target of praziquantel},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
doi = {10.1371/journal.pntd.0011929}
}
EUVIMED